Introduction: The use of laparoscopy for the excision of adrenal metastasis remains controversial.
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ABSTRACT:
Introduction: The use of laparoscopy for the excision of adrenal metastasis remains controversial.
We aimed to report oncological and perioperative outcomes of laparoscopic excision of adrenal metastases and to seek for predictive factors of unfavourable oncological outcomes.
Methods:
A retrospective chart review was conducted and all consecutive patients who underwent laparoscopic adrenalectomy (LA) in the setting of metastatic cancer in two academic urology departments from November 2006 through January 2014 were included. Primary tumors were categorized as pulmonary, renal or "other primary" tumors to allow statistical comparison.
Unfavourable surgical outcomes were defined as the occurrence of either postoperative complications and/or positive surgical margins.
Results:
Forty-three patients who underwent a total of 45 LA were included for analysis. There were 8 complications (17.8%). Positive surgical margins were found in 12 specimens (26.7%). After a median follow-up of 37 months, estimated overall survival rates were 89.5% and 51.5% at 1 year and 5 years, respectively. In multivariable analysis the only predictor of unfavourable surgical outcomes was a tumor size > 5 cm (OR= 20.5; p=0.001). In multivariate analysis the pulmonary (OR=0.3; p=0.008) or "other" (OR= 0.1; p=0.0006) origin of the primary tumor was the only prognostic factor of shorter cancer specific survival. 
Conclusion

Introduction
Despite a low level of evidence, adrenalectomy is now recommended in case of isolated adrenal metastasis [1] [2] , as many retrospective series have shown the oncological benefit of surgical excision in this situation [3] .
Firstly reported by Gagner et al. in 1992 [4] , laparoscopic adrenalectomy (LA) has become the goldstandard treatment of benign adrenal tumors. Several series have proven the lower morbidity of this approach in adrenal surgery (notably decreased complication rate and blood loss, shorter length of stay) [5] [6] . Although most of the series of LA have shown similar surgical and oncological outcomes to those reported in the open era [7] [8] , the role of laparoscopy in the treatment of malignant adrenal tumors remains controversial. In recent years, two series have raised concern about the laparoscopic approach for resection of adrenal metastases. In a single center cohort of 16 patients, Sebag et al. noted high rates of positive surgical margins, complications and conversion to open surgery [9] . In their single-center series of 13 patients, Crenn et al reported similar findings [10] .
In this work, we therefore hypothesized that both the adrenal resection in itself and the laparoscopic approach could not be beneficial for every patient with isolated adrenal metastasis. We aimed to report oncological and perioperative outcomes of laparoscopic excision of adrenal metastases and to look for predictive factors of unfavourable surgical outcomes in order to determine which patients could benefit of laparoscopic resection of adrenal metastases.
Patients and methods
M
A N U S C R I P T A C C E P T E D [12] . Metastases were considered as synchronous if detected within 6 months after treatment of the primary tumor. Otherwise, they were defined as metachronous.
Diseases were categorized as isolated (only one adrenal metastasis) or oligometastatic (other synchronous metastasis or history of previous metastasis). Unfavourable surgical outcomes were defined as the occurrence of either postoperative complications and/or positive surgical margins.
Primary tumors were categorized as pulmonary, renal or "other primary" tumors to allow statistical comparison between groups. Tumors sizes were categorized as > 5cm or 5 cm.
Our main objective was to determine predictors of unfavourable surgical and oncological outcomes.
Our secondary objective was to report outcomes of LA in a multicenter study.
b. Surgical techniques
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All surgeries were performed laparoscopically. However, some procedures were performed through a transperitoneal approach whereas others were carried out by a retroperitoneal route. The choice of either the transperitoneal or retroperitoneal approach was left to surgeon's discretion. In one of the department all LA were performed through a transperitoneal approach while both approaches were used in the other department.
c. Patients follow-up
All patients were evaluated by their surgeon at an outpatient appointment 1 month after surgery. All complications occurring during the first post-operative month were collected and considered as postoperative complications. Further oncological follow-up was then left to the oncologist and involved a physical examination and imaging every six months during the first two years and then annually for a minimum of 5 years.
d. Statistical Analysis
Means and standard deviations were reported for continuous variables and proportions for qualitative and categorical variables. Comparisons between groups were performed using 2 test and Fisher exact test for discrete variables and student t test for continuous variables. To confirm the findings of univariate analysis, a logistic regression model was used to assess predictors of unfavourable surgical outcomes. Overall survival (OS), cancer-specific survival (CSS) and recurrence-free survival (RFS)
were estimated using the Kaplan-Meier method and compared with the log-rank test. A Cox proportional hazards regression model was used to define the prognostic factors. Statistical analyzes were conducted using JMP v.10.0 software (SAS Institute Inc, Cary, NC, USA). All tests were twosided with a significance level at p< 0.05. 
Results
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Discussion
Surgical resection of adrenal metastasis has gained wide acceptance over the past decade in case of isolated or oligometastatic disease and is now considered as the standard treatment in this situation [1] [2] [3] . However there is a paucity of data to support this management and no randomized evidence to suggest that local therapy of adrenal metastases alters the natural course of the disease [13] . In the only large case-control study to date, Vazquez et al compared survivals of their patients treated with M A N U S C R I P T
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adrenalectomy for adrenal metastasis to those of SEER-database stage-matched patients with no resection of adrenal metastases. They found a survival benefit in favour of surgical resection for metastases arising from lung, kidney, pancreas and sarcoma but their findings are debatable due to their study design [14] . Our results reinforce those previously reported in the literature by showing that resection of adrenal metastases may be associated with prolonged survival (5-year CSS and RFS rates: 53.3% and 26.4%, respectively) [3, [7] [8] [9] [10] [13] [14] . However, our 5-year CSS rate exceeds those reported in other series (from 30 to 40%) [3, [7] [8] [9] [10] [13] [14] . This may be due to the larger proportion in our series of patients with renal cell carcinoma who have been shown to have a significantly better prognosis compared with other primary tumors [8, [15] [16] .
To date, only 5 series analyzed prognostic factors for resected adrenal metastases using a Cox regression model [8, [15] [16] [17] [18] . Out of these studies, three showed a better prognosis in multivariate analysis for metastases from renal carcinoma [8, [15] [16] . Our results confirm that a primary renal tumour is the main prognostic factor in surgical excision of adrenal metastases. Conversely, we did not find a prognostic impact for factors such as tumor size, type of treatment of the primary tumor (surgery, radiotherapy, …) or status of margins, which have ever been reported by others [8, [15] [16] [17] [18] .
This could be due to the relatively small sample size of our study.
The present study is the first to report complications of surgery of adrenal metastases in a standardized way (i.e. using Clavien score [11] , with respect of the EAU guidelines [12] ). We report a complication rate similar to those previously published in the literature: 17.8% in our series versus 4 to 20% in other laparoscopic series [7, 9, 15, [18] [19] . These complications rates seem overall comparable to the complication rates of open surgical adrenalectomies (6 to 20% [13, 18] ) but no firm conclusions can be established due to the lack of standardization of the complications report in most studies.
In our study we used the concept of an unfavourable surgical outcome in the presence of post- for metastasis [15, 17] We found that a metastasis size > 5 cm was the only predictor of an unfavourable surgical outcome in multivariate analysis. Most authors advocate an open surgical approach for the excision of bigger lesions however the upper limit proposed for a laparoscopic approach varies in different studies [21] [22] . While it is quite obvious that excision of bigger lesions will involve a higher risk of complications and positive surgical margins, there is no firm evidence that an open approach would obtain a better surgical outcome. Our series similarly to most other published series did not have a control group and could not answer this question [3] . Due to the non-controlled design of our study we could not bring new evidence concerning the potential survival benefits of resection of adrenal metastasis compared to a non-surgical management. Another limitation of the present study is its retrospective nature, which can introduce selection and ascertainment bias. Finally, systemic therapies that have been shown to impact prognosis in other studies [17] were not taken into account in our series.
Conclusion
Laparoscopic resection of adrenal metastasis can be safely performed in most patients but is associated with an increased risk of positive surgical margins and of postoperative complications in larger tumors (size 5 cm). Adrenalectomy for metastasis can be associated with a prolonged survival in selected patients and provide better oncological outcomes in metastases from renal cell carcinoma compared to other primary tumors. 
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